Yahoo Web Search

Search results

    • Moderna Drug Candidate Tapped for FDA Rare-Disease Pilot Program

      Morningstar· 2 hours ago

      By Colin Kellaher Moderna's mRNA-3705 drug candidate for a rare, genetic disorder of the liver has been chosen for a Food and Drug Administration pilot program aimed at addressing unmet medical needs for rare diseases. Moderna on Thursday

    • FDA Panel Rejects MDMA Drug for PTSD

      Medscape· 1 day ago

      A US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for ...